Trial Profile
Steady-State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV-Negative Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Mar 2013
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Lopinavir/ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Tibotec Inc
- 07 Mar 2013 New trial record